Using treatment guidelines to improve antibiotic use: insights from an antibiotic point prevalence survey in Kenya.

Maina M, McKnight J, Tosas-Auguet O, Schultsz C, English M.

BMJ Glob Health.. ; 6 : e003836

Malaria micro-stratification using routine surveillance data in Western Kenya.

Alegana VA, Suiyanka L, Macharia PM, Ikahu-Muchangi G, Snow RW.

Malar J.. ; 20 : 22

Applying a gender lens to understand pathways through care for acutely ill young children in Kenyan urban informal settlements.

Muraya K, Ogutu M, Mwadhi M, Mikusa J, Okinyi M, Magawi C, Zakayo S, Njeru R, Haribondhu S, Uddin MF, Marsh V, Walson JL, Berkley J, Molyneux S.

Int J Equity Health.. ; 20 : 17

Unit costs and other musings: a response.

Torres-Rueda S, Ferrari G, Orangi S, Hitimana R, Daviaud E, Tawiah T, Prah RKD, Karmaliani R, Kapapa E, Barasa E, Jewkes R, Vassall A.

Health Policy Plan.. ; 36 : 223-225

Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria – Authors’ reply

Ackerman H, Olola CHO, Krishna S, Roberts DJ, Kremsner PG, Newton CR, Taylor T, Valim C, Casals-Pascual C.

Lancet Haematol.. ; 8 : e12-e13.

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.

Jamrozik E, Littler K, Bull S, Emerson C, Kang G, Kapulu M, Rey E, Saenz C, Shah S, Smith PG, Upshur R, Weijer C, Selgelid MJ; WHO Working Group for Guidance on Human Challenge Studies in COVID-19.

vaccine. ; 39 : 633-640

Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.

Pett SL, Spyer M, Haddow LJ, Nhema R, Benjamin LA, Najjuka G, Bilima S, Daud I, Musoro G, Kitabalwa J, Selemani G, Kandie S, Cornelius KM, Katemba C, Berkley JA, Hassan AS, Kityo C, Hakim J, Heyderman RS, Gibb DM, Walker AS

AIDS. ; 35 : 585-594.